Hypothalamic bile acid-TGR5 signaling protects from obesity.
GPBAR1
TGR5
bile acids
body weight
diet
energy expenditure
food intake
hypothalamus
obesity
sympathetic nervous system
Journal
Cell metabolism
ISSN: 1932-7420
Titre abrégé: Cell Metab
Pays: United States
ID NLM: 101233170
Informations de publication
Date de publication:
06 07 2021
06 07 2021
Historique:
received:
23
10
2020
revised:
30
03
2021
accepted:
14
04
2021
pubmed:
23
4
2021
medline:
31
3
2022
entrez:
22
4
2021
Statut:
ppublish
Résumé
Bile acids (BAs) improve metabolism and exert anti-obesity effects through the activation of the Takeda G protein-coupled receptor 5 (TGR5) in peripheral tissues. TGR5 is also found in the brain hypothalamus, but whether hypothalamic BA signaling is implicated in body weight control and obesity pathophysiology remains unknown. Here we show that hypothalamic BA content is reduced in diet-induced obese mice. Central administration of BAs or a specific TGR5 agonist in these animals decreases body weight and fat mass by activating the sympathetic nervous system, thereby promoting negative energy balance. Conversely, genetic downregulation of hypothalamic TGR5 expression in the mediobasal hypothalamus favors the development of obesity and worsens established obesity by blunting sympathetic activity. Lastly, hypothalamic TGR5 signaling is required for the anti-obesity action of dietary BA supplementation. Together, these findings identify hypothalamic TGR5 signaling as a key mediator of a top-down neural mechanism that counteracts diet-induced obesity.
Identifiants
pubmed: 33887197
pii: S1550-4131(21)00175-3
doi: 10.1016/j.cmet.2021.04.009
pii:
doi:
Substances chimiques
Bile Acids and Salts
0
Gpbar1 protein, mouse
0
Receptors, G-Protein-Coupled
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1483-1492.e10Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.